The Board of NeoDynamics has extensive experience from medical technology, pharmaceutical, and financial businesses.

*Independent in relation to NeoDynamics AB (publ), its management, and the principal shareholders.

Ingrid Salén

Independent* chairperson of the Board since 2016.
Education: Civil engineer.
Work/experience: Scania CV AB - several roles - Global Purchasing between 1995 and 2009. Maquet Critical Care AB - Director of Sourcing and Supplier Management between May 2012 and Mar 2014.
Board memberships: Chairperson of the Board at Garpco AB and Developeration AB.
Holds: 895,245 shares via Rentability Sweden AB.

Carina Bolin

Independent* Board member since 2018.
Education: Lawyer (Jur.kand; equiv. to LL.M).
Work/Experience: Approx. 35 years of experience from work as a legal counsel, 30 years of which in internationally operating organisations. Legal consultant in own company since 2020. Previously, general counsel for companies in life science/medical technology (Olink Proteomics AB and Q-Med AB), legal counsel in several other organisations, incl. ABB AB and IP law firm Brann AB.
Board memberships: Previously Chairperson of the Board at, among others, Academicum Utbildning & Bemanning AB, Apoteksammariten AB, and Board member at several corporate subsidiaries.
Holds: 48,780 shares.

Claes Pettersson

Independent* Board member since 2015.
Education: Engineer and economics degree.
Work/experience: CEO and/or Board member in 25 wholly or partially owned companies in several business sectors. Co-founder of, and executive roles in, Alfaskop AB (publ). CFO at Kreatel Communications AB, Sick IVP AB and AMRA Medical AB. CFO and CEO assignment at Impact Coatings AB (publ). Today, he works part-time as CFO at XMReality AB (publ), a member of LiU Invest, a Linköping University department for providing seed funding to the university's spin-offs.
Board memberships: Board member or Chairperson of the Board at several smaller high-growth companies. Board member and Vice-chairperson of the Board at Åtvidabergs Sparbank
Holds: 485,668 shares.

Matthew E. Colpoys, Jr.

Independent* Board member since 2021.
Education: Degree from Canisius College.
Work/experience: More than 35 years of experience from the pharmaceutical industry with commercial, business development and leadership roles at Genentech, Pharmacia, Neurex, Insmed, and others. Current president at Galileo Consulting, a global biopharmaceutical advisory and consulting company.
Board memberships: -
Holds: 0 shares.